Bausch + Lomb Corporation (NYSE:BLCO) Q1 2024 Earnings Call Transcript May 1, 2024 Bausch + Lomb Corporation misses on ...

Revenue exceeded analyst estimates by 2.9%. Earnings per share (EPS) missed analyst estimates significantly. Looking ahead, ...

Dog owners often use wipes to keep their pets’ eyes clean and healthy. But Bausch + Lomb is recalling 32,000 units is its ...

BLCO stock results show that Bausch & Lomb met analyst estimates for earnings per share but missed on revenue for the first ...

The company said consumers should immediately stop using the eyelid wipes because harmful contamination growth can form in ...

Warning! GuruFocus has detected 5 Warning Signs with BLCO. Bausch & Lomb Corp (NYSE:BLCO) released its 8-K filing on May 1, ...

Bausch + Lomb releases figures for Q1.Wall Street analysts expect Bausch + Lomb will report earnings per share of $0.070.Follow Bausch ...

GAAP Earnings Per Share (“EPS”) Basic and Diluted attributable to Bausch + Lomb Corporation for the first quarter of 2024 was ($0.48), as compared to ($0.26) for the first quarter of 2023. Adjusted ...

By Robb M. Stewart Bausch Health's loss in the latest quarter narrowed after the pharmaceutical company's revenue was bolstered by increased sales in each ...

A recall was issued for Bausch + Lomb's Project Watson dog eyelid wipes because of the risk that fungi and bacteria can begin to grow in the containers, posing a risk of infection for pets ...